Impurities-the hidden danger in anticonvulsant drugs.
Sabroe
Thomas Peter
TP
D000927:Anticonvulsants / Q000009:adverse effects / Q000737:chemistry* / Q000493:pharmacokinetics*; D001682:Biological Availability; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D004340:Drug Contamination / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data*; D016568:Drugs, Generic / Q000592:standards; D006801:Humans; D000077213:Lamotrigine; D009426:Netherlands; D014227:Triazines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000927:Anticonvulsants; D016568:Drugs, Generic; D014227:Triazines; D000077213:Lamotrigine